Lineage Cell Therapeutics, Inc. is a clinical-stage biotechnology company located in Carlsbad, California, dedicated to developing and commercializing innovative cell-based therapies for degenerative diseases. The firm emphasizes regenerative medicine and utilizes proprietary technologies to tackle significant unmet medical needs on a global scale. With a diverse and promising pipeline bolstered by strategic collaborations, Lineage is well-positioned for growth as it advances its clinical candidates. Its commitment to pioneering regenerative therapeutics presents a compelling investment opportunity for institutional investors focused on the future of biotech innovation.

NYSE MKT

USA

HEALTHCARE

BIOTECHNOLOGY

2173 SALK AVENUE, CARLSBAD, CA, UNITED STATES, 92008

December

$405 Million

-$19.7 Million

0.0

-0.29

$0.00

0.0%

1.749